Daisuke Kotani, GI Medical Oncologist, Chief Physician at the Department of Gastrointestinal Oncology at the National Cancer Center Hospital East, Japan, shared a post on X:
“Protocol Paper: Ph2 FP + ICI vs Palliative RT ± FP followed by FP + ICI for ESCC with Severe Dysphagia.”
Title: A pragmatic phase II trial evaluating treatment strategies using immune checkpoint inhibitors for metastatic esophageal cancer patients with severe dysphagia
Authors: Y. Nagata, H. Arai, N. Izawa, C. Inagaki, A. Sugaya, K. Hirata, T. Tsushima, T. Moriwaki, T. Masuishi, Y. Nagatani, K. Harada, M. Taguri, Y. Sunakawa
Read The Full Article
Other articles about ESCC on OncoDaily.